This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Other. Active years: 2006-2013.
Company Filing History:
3 out of 834,307 Years Active: 2006-2013
Title: Ingolf-Pascal Surel: Innovator in Peptide Technology
Introduction
Ingolf-Pascal Surel is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of peptide technology, particularly in the context of vaccinations and immune response. With a total of 3 patents, his work has implications for medical advancements in immunology.
Latest Patents
One of his latest patents is focused on "Peptides for vaccination against human CMV." This invention relates to peptides or pretide derivatives of the 65kD lower matrix phosphoprotein of human cytomegalovirus. The disclosed peptides are useful for determining whether subjects have been exposed to human cytomegalovirus. Additionally, methods for using these peptides or derivatives to determine the peptide-induced production of interferon-γ and/or TNF-α in CD8 T cells isolated from subjects are also included.
Another significant patent is titled "Method for antigen-specific stimulation of T lymphocytes with synthetic peptide libraries." This invention outlines a method for the antigen-specific stimulation of T-lymphocytes using a synthetic peptide library. The process involves preparing a plurality of peptides, each comprising a fragment of the total amino acid sequence of the antigen, with each peptide being a minimum of 9 amino acid residues in length. The peptides are combined into a library that spans the total amino acid sequence of the antigen, and then incubated with a suspension of CD8+ T lymphocytes, CD4+ T lymphocytes, or a mixture of both.
Career Highlights
Ingolf-Pascal Surel has worked with various companies throughout his career, contributing to advancements in peptide technology. His experience has allowed him to develop innovative solutions that address critical challenges in immunology.
Collaborations
Throughout his career, Ingolf-Pascal Surel has collaborated with notable individuals such as Florian Kern and Petra Reinke. These collaborations have further enriched his work and contributed to the success of his inventions.
Conclusion
Ingolf-Pascal Surel is a distinguished inventor whose work in peptide technology has the potential to impact the field of immunology significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.